Ribavirin/interferon alpha combination for the treatment of chronic hepatitis C: What is the current situation?;Ribavirin/interferon-alpha-kombination zur behandlung der chronischen hepatitis C: Wo stehen wir heute?

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 1-2, 1999, Pages 8-10

  Renner, E L ^a  

^a Abteilung für Gastroenterologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL PROTOCOL; HEPATITIS C; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; HEPATITIS C, CHRONIC; HUMANS; RANDOMIZED CONTROLLED TRIALS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 0033547723     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Reichhard O, Norkrans G, Frydén A, et al. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;352:83-7.
2. Poynard T, Mercellin P, Lee SS, et al. Randomised trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352:1426-32.
3. McHutchison J, Gordon SC, Schiff ER, et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
4. Chemello L, Bonetti P, Cavaletto L, et al. Randomized trial comparing three different regimes of alpha-2a-interferon in chronic hepatitis C. Hepatology 1996;24:700-6.
5. Poynard T, Leroy V, Cohard M, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effect of dose and duration. Hepatology 1998;24:778-89.
6. Davis G, Esteban-Mur E, Rustgi V, et al. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339:1493-9.